Mechanisms of Emerging RNA Virus Adaptation to Hosts
| dc.contributor.author | Cereghino, Chelsea Nevins | en |
| dc.contributor.committeechair | Weger, James David | en |
| dc.contributor.committeemember | Duggal, Nisha | en |
| dc.contributor.committeemember | Draghi, Jeremy | en |
| dc.contributor.committeemember | Kehn-Hall, Kylene Wesley | en |
| dc.contributor.department | Biomedical and Veterinary Sciences | en |
| dc.date.accessioned | 2025-12-17T09:00:37Z | en |
| dc.date.available | 2025-12-17T09:00:37Z | en |
| dc.date.issued | 2025-12-16 | en |
| dc.description.abstract | Emerging RNA viruses cause acute and chronic diseases that threaten the livelihoods of people in regions where the virus is endemic. As factors such as climate change and increased globalization, travel, and trade alter the co-occurrence of humans and reservoirs or vectors, opportunities for viral geographic expansion or viral spillover increase. Viral adaptation enabling intra- or interspecies transmission can cause outbreaks on the scale of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the coronavirus disease 2019 pandemic. Understanding the mechanisms by which emerging RNA viruses adapt to hosts can inform public health strategies targeting the appropriate vectors and reservoirs of the virus or the design of effective therapeutics. Therefore, we sought to identify the viral genetic determinants of host adaptation of two contrasting viruses, Mayaro virus (MAYV) and SARS-CoV-2. We used either selective sweep detection methods or experimental evolution to identify viral mutations with putative adaptive potential. A selective sweep region was identified in the Spike gene of human SARS-CoV-2 sequences. A residue at site 519 in this region of Spike was identified that differed from that of closely related sarbecoviruses infecting bats and pangolins. The ancestral mutation H519N reduced the entry of pseudotyped viruses in human ACE2 (hACE2)-expressing cells and decreased replication in human lung cells through reduced hACE2 binding. Next, serial passaging of SARS-CoV-2 in cells expressing the animal ACE2 receptor identified the recurring mutation A222V in the Spike gene. Spike A222V enhanced replication of SARS-CoV-2 in primary white-tailed deer lung cells through an ACE2-independent mechanism. Lastly, serial passaging of MAYV in cells from two urban mosquito vectors, Aedes aegypti and Aedes albopictus, identified a mutation in E2, T179N, that increased viral fitness in these cells. E2-T179N increased the transmission efficiency of MAYV by Aedes aegypti while coming at the cost of reduced fitness and virulence in mice. Taken together, these works highlight the impact of single mutations on virus fitness within and between hosts. Our findings underscore the importance of combining surveillance, limiting specific reservoir and vector exposure, and therapeutic design targeting adaptive residues to prevent the further evolution and emergence of SARS-CoV-2 and MAYV. | en |
| dc.description.abstractgeneral | Viruses can cause short- and long-lived diseases that affect the wellbeing of people living in areas where the virus circulates. In recent years, increased globalization, travel, trade, and climate change has led both to the outbreak of new viruses and an increase in the scale of outbreaks for pre-existing viruses. These changes can result from increased exposure to animals that carry disease, such as mosquitoes or wild animals. The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease 2019 pandemic, displayed how virus evolution can lead to new diseases in humans. Understanding how virus evolution impacts the infection of a human, animal, or an insect can aid in the design of vaccines or drugs effective against new virus mutations that may, for example, lead to more severe disease in humans. To identify mutations in viruses that adapt the virus to different hosts, we used two viruses: the mosquito-borne Mayaro virus and SARS-CoV-2. First, we searched sequences of SARS-CoV-2 from humans and identified a region in Spike, the virus protein responsible for binding to the host receptor, that had undergone recent evolution. This region in Spike contained an amino acid unique to SARS-CoV-2 that was not found in related viruses that infect bats. We generated a SARS-CoV-2 mutant containing the bat virus amino acid and measured both a decreased ability of the mutant virus to enter human lung cells and decreased virus replication. We showed that the more bat virus-like SARS-CoV-2 could not bind as well to the host cell receptor to enter human cells. Next, we allowed SARS-CoV-2 to evolve in cells containing the receptor of either dogs, cats, mink, or deer, a proxy for animal infection. The resulting virus acquired a mutation in Spike that increased SARS-CoV-2 replication in deer lung cells but not in human lung cells. The Spike mutation in SARS-CoV-2 has been identified in nature repeatedly across time, including in SARS-CoV-2 infecting dogs, cats, mink, and deer. Finally, we allowed Mayaro virus to evolve in two cell types from mosquitoes and identified a mutation in a protein that binds to the host cell receptor. This mutation increased the replication of Mayaro virus in mosquito cells and enhanced the transmission of Mayaro virus in live mosquitoes. We infected mice with the mutant virus and observed both decreased amounts of virus in the blood and decreased evidence of disease, suggesting this mutation may negatively impact the virus in a human host. Our studies identified mutations that may have been important for SARS-CoV-2 to initially infect humans and be maintained in wild animal populations such as deer, or for Mayaro virus, to be transmitted more efficiently by mosquitoes. Identification of these mutations in nature could provide evidence that the virus has evolved in a way that could promote outbreaks. Therefore, it is important to design vaccines or antivirals that are effective against viruses with these mutations and to routinely test animals or mosquitoes to identify mutated viruses that could pose threats to humans. | en |
| dc.description.degree | Doctor of Philosophy | en |
| dc.format.medium | ETD | en |
| dc.identifier.other | vt_gsexam:45285 | en |
| dc.identifier.uri | https://hdl.handle.net/10919/139935 | en |
| dc.language.iso | en | en |
| dc.publisher | Virginia Tech | en |
| dc.rights | Creative Commons Attribution 4.0 International | en |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en |
| dc.subject | host adaptation | en |
| dc.subject | Mayaro virus | en |
| dc.subject | severe acute respiratory syndrome coronavirus 2 | en |
| dc.subject | genetic determinants | en |
| dc.title | Mechanisms of Emerging RNA Virus Adaptation to Hosts | en |
| dc.type | Dissertation | en |
| thesis.degree.discipline | Biomedical and Veterinary Sciences | en |
| thesis.degree.grantor | Virginia Polytechnic Institute and State University | en |
| thesis.degree.level | doctoral | en |
| thesis.degree.name | Doctor of Philosophy | en |